Advertisement

Role of Immune Response in HCV

  • Marion Peters
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 19)

Abstract

The liver cell response to hepatitis C, a positive-strand RNA virus of the flaviviridiae, varies considerably from acute disease to chronic hepatitis, and from inapparent infection to cirrhosis. The cellular injury to the host depends on host—viral interactions (Table 1): in general, the more active the immune response, the greater the cellular injury. If viral infection leads to cell lysis, then the organism dies as is seen in fulminant hepatitis, a relatively rare event (<1% response seen after hepatotrophic viral infection and rare in HCV infection). If cellular dysfunction occurs, then clinical disease results. If viral replication occurs without cellular damage, then inapparent infection results. If the individual is exposed without attachment to the host, then no infection occurs
Table 1

Host-Cell Response: Outcome of HCV Infection

Cellular response

Host response

HCV

Cell lysis

Death of organism

Fulminant failure rare

Viral multiplication without cell damage

Asymptomatic infection

Inapparent disease <15%

Cell dysfunction

Climical disease

Common

Exposure without attachment

Exposure, no infection

Unknown

Keywords

Natural Killer Cell Cellular Injury Altered Peptide Ligand Nonspecific Response Inapparent Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Peters, M., Davis, G. L., Dooley, J. S., and Hoofnagle, J. H. (1986) The interferon system in acute and chronic viral hepatitis. Prog Liver Dis. 89, 453–468.Google Scholar
  2. 2.
    Peters, M (1996) Actions of cytokines on the immune response and viral interactions: an overview. Hepatology 23, 909–916PubMedCrossRefGoogle Scholar
  3. 3.
    Carli, M, Fiaccadori, F., and Ferrari, C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells Nature 369, 407–410PubMedCrossRefGoogle Scholar
  4. 4.
    Koziel, M. J. (1996) Immunology of viral hepatitis Am. J. Med 100, 98–109.PubMedCrossRefGoogle Scholar
  5. 5.
    Scheuer, P J, Ashrafzadeh, P., Sherlock, S., et al. (1992) The pathology of hepatitis C. Hepatology 15, 567–571.PubMedCrossRefGoogle Scholar
  6. 6.
    Mondelli, M U, Cerino, A., Bellotti, V, and de Koning, A. (1993) Immunobiology and pathogenesis of Hepatitis C virus infection. Res Virol. 144, 269–274.PubMedCrossRefGoogle Scholar
  7. 7.
    Nelson, D. R, Marousis, C. G., Davis, G. L., et al. (1997). The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol. 158, 1473–1481.PubMedGoogle Scholar
  8. 8.
    Koziel, M J, Dudley, D, Wong, J. T., et al. (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in person with chronic hepatitis J Immunol 149, 3339–3344.PubMedGoogle Scholar
  9. 9.
    Koziel, M. J., Dudley, D., Afdhal, N., et al (1993) Hepatitis C virus specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67, 7522–7532PubMedGoogle Scholar
  10. 10.
    Kaneko, T., Nakamura, I, Kita, H, et al (1996) Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein. J. Gen Virol 77, 1305–1309.PubMedCrossRefGoogle Scholar
  11. 11.
    Minutello, M A., Pileri, P, Unutmaz, D., et al. (1993) Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C J Exp. Med 178, 17–25.PubMedCrossRefGoogle Scholar
  12. 12.
    Diepolder, H. M., Zachoval, R, Hoffmann, R. M, et al. (1995) The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol. Med 74, 583–588.CrossRefGoogle Scholar
  13. 13.
    Hoffmann, R. M, Diepolder, H. M., Zachoval, R., et al (1995) Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection Hepatology 21, 632–638.PubMedGoogle Scholar
  14. 14.
    Farci, P., Alter, H. J., Govindarajan, S., et al. (1992) Lack of protective immunity against reinfection with Hepatitis C virus. Science 258, 135–140PubMedCrossRefGoogle Scholar
  15. 15.
    Mondelli, M. U., Cividini, A., and Cerino, A. (1997) Role of humoral immune responses in hepatitis B and C virus infections Eur. J. Clin. Invest 25, 543–547CrossRefGoogle Scholar
  16. 16.
    Diepolder, H. M., Zachoval, R., Hoffmann, R. M., et al. (1995). Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 14, 1006,1007.CrossRefGoogle Scholar
  17. 17.
    Nelson, D R, Gray, A. H., Kolberg, J A., et al. (1995) Variations of hepatitis C virus NS5B sequence (nucleotides 8261–8566) do not correlate with response to interferon-alpha therapy J Viral Hepatol 2, 285–292CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1998

Authors and Affiliations

  • Marion Peters
    • 1
  1. 1.Department of MedicineWashington University School of MedicineSt. Louis

Personalised recommendations